Braze Investor Day Presentation Deck
Realizing R&D Efficiencies as We Scale
Non-GAAP Measures
Gross Margin
S&M expense as % of revenue
R&D expense as % of revenue
G&A expense as % of revenue
Operating Margin
H1 FY'23
68.6%
51.7%
19.3%
19.3%
(21.7%)
37
1. Reflects our long-term targets, which are not projections or estimates of future financial results. Our ability to achieve these long-term targets is subject to various risks and uncertainties. There are important factors that
could cause our future results to differ materially from those suggested by these long-term targets, including, but not limited to, the risks an uncertainties described under the heading "Risk Factors in our Quarterly Report on
Form 10-Q for the period ended July 31, 2022 and filed with the SEC on September 13, 2022. There can be no assurance that we will achieve the long-term targets presented on this slide in a timely manner or at all. Please see
Slide 3 for additional information regarding forward-looking statements.
Long-Term Target¹
13 - 15 %
~20%
R&D Levers
Efficiencies in our
engineering
infrastructure and
headcount as we scale
. Continue sustaining
investments in product
innovation to fuel
growth
Note: Braze operates on a January 31 fiscal year end
See Appendix for GAAP to non-GAAP Reconciliations and other key definitions
brazeView entire presentation